National Cancer Prevention Month: What You Need to Know

Article

With February being National Cancer Prevention Month, here are the latest updates in cancer prevention.

According to a study conducted by the American Cancer Society, at least 42% of newly diagnosed cancers in the US, which translates to about 750,000 cases in 2020, are potentially avoidable. This includes the 19% of all cancers that are caused by smoking and the 18% caused by a combination of excess body weight, alcohol consumption, poor nutrition, and physical inactivity.

With February being National Cancer Prevention Month, here is a round-up of the latest news and updates that focus on the role of cancer prevention:

  • Over the next century, successful implementation of the World Health Organization (WHO) elimination strategy could reduce cervical cancer mortality by almost 99% and save more than 62 million women’s lives.

  • A recent study determined circulating tumor cells were associated with melanoma relapse, suggesting that this form of liquid biopsy could help identify patients who would benefit from adjuvant therapy.

  • According to researchers, when individuals quit smoking it not only stops further damage from accruing, but it also may lead to the reawakening of lung cells that were not damaged by tobacco carcinogens.

  • A new AI system could possibly surpass human experts in the prediction of breast cancer, potentially leading to enhanced screening results and earlier identification of the disease. 

  • Online and digital videos were found to play a key role in cancer education, leading to increased knowledge and interventions, however access for vulnerable populations needs to be improved. 

  • Engaging in the recommended amount of leisure-time physical activity (7.5-15 MET hours/week) was found to be associated with a lower risk for 7 different cancer types.

  • Greater adherence to the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) cancer prevention recommendations appeared to be associated with decreased colorectal cancer (CRC) risk for both African Americans and whites.

  • A blood-based screening test, presented at the 2020 Gastrointestinal Cancers Symposium, held from January 23-25, in San Francisco, California, could potentially diagnose multiple cancer types earlier, includinggastrointestinal cancers across stages at high sensitivity.

Reference:

American Cancer Society. Cancer Facts & Figures 2020. American Cancer Society Website. Published 2020. cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf. Accessed February 18, 2020.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.